Mayo Clinic
200 1st Street SW
Rochester
Minnesota
55905
United States
Tel: 507-284-2511
Fax: 507-284-0161
Website: http://www.mayo.edu/
769 articles with Mayo Clinic
-
With the JP Morgan Healthcare Conference ending today, it’s worth noting the word “healthcare” in the title, not “biopharma.” It’s not as if the biotech and pharmaceutical industry isn’t part of healthcare, but BioSpace’s reporting focuses on biopharma. Here’s a look at some of the more healthcar...
-
Exemplar Genetics and Mayo Clinic Launch Joint Venture Focused on Development of Human Liver Cells to Advance Medical Research
12/21/2018
Exemplar Genetics, a subsidiary of Intrexon Corporation (NASDAQ: XON) and market leader in the development of genetically engineered miniswine as models of human disease, and Mayo Clinic have launched a joint venture focused on the development of a high quality source of human liver cells or hepatocytes (HHCs).
-
Mayo Clinic obesity startup launches $1M seed round
11/28/2018
Phenomix Sciences, an early stage Mayo Clinic startup company focused on personalizing chronic disease treatment, announced today it is opening up its seed round of financing to enable commercialization of a new clinical test for obesity.
-
One of the drugs being discussed this week by a U.S. Food and Drug Administration advisory committee is Waltham, Mass.-based Alkermes’ ALKS-5461. The drug itself has some controversy.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded by an $11 Million U.S. Department of Defense Grant
10/10/2018
Mayo Clinic Receives $11 Million to Study TPIV110 in Combination with Trastuzumab (Herceptin®)
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S.
10/2/2018
Collaboration combines the clinical expertise of Mayo Clinic and Baxter Renal Care Services
-
ImmunogenX Completes CypCel Trial for Celiac Disease
9/27/2018
Further validation of minimally-invasive monitor of celiac villous intestinal health
-
A commercially-available medical device developed by Medtronic is helping paralyzed patients walk again.The device, which stimulates the spinal cord through electrical pulses, has been successful in helping some individuals who lost the ability to walk through injuries to their spine, regain the ...
-
September 21 Research Roundup: Zombie Cells, Pancreatic Cancer, Household Cleaners and Obesity, a...
9/21/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
The death of Sen. John McCain helped raise awareness about the plight of brain tumor patients and the lack of movement on developing new therapies for this disease over the past several years. But now, Houston-based Moleculin Biotech has launched a clinical trial that could be a game-changer if a...
-
Tempus Data Analytics Firm Hits $2 Billion Valuation, One of a Handful of Chicago “Unicorns”
9/5/2018
On August 29, Chicago-based Tempus, which focuses on data analytics for molecular and clinical data, announced it had raised $110 million in Series E financing. This brought total money raised so far to $320 million. This also gave the company a valuation of $2 billion. -
APEIRON EXPANDS EXECUTIVE BOARD AND APPOINTS DR. ANDERSON GAWECO AS CHIEF MEDICAL AND SCIENTIFIC OFFICER (CMSO)
8/28/2018
APEIRON Biologics AG, a biotechnology company with a broad preclinical and clinical pipeline and an approved product on the market, focusing on the discovery and development of novel cancer immunotherapies, announced today the appointment of Anderson Gaweco, M.D., Ph.D. as its Chief Medical and Scientific Officer (CMSO).
-
Accountable Care Learning Collaborative and Leading Provider Organizations Respond to Calls for Value-Based Transformation of US Health Care
8/28/2018
Today, the Accountable Care Learning Collaborative (ACLC) is pleased to release ten new Case Study Briefs (CSBs) in partnership with leading provider organizations - including Mayo Clinic, Ascension, and Montefiore Health System - each offering a concise, tactical account of a value-based solution successfully implemented.
-
According to the National Cancer Institute (NCI), pancreatic cancer is relatively rare, with about 55,440 cases diagnosed annually, representing about 3.2 percent of new cancer cases. But each year, 44,330 Americans die from the disease, or about 7.3 percent of cancer deaths.
-
Sensyne Health, a London-based healthcare artificial intelligence (AI) company founded by biotech entrepreneur Paul Drayson, recently launched an initial public offering (IPO) on the London AIM market. Drayson’s plan is to raise $78 million. It’s just one of many companies that are exploiting adv...
-
Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
8/16/2018
Elysium Health, Inc.™ has entered into an exclusive license agreement with Mayo Clinic and Harvard University.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
Researchers at the Mayo Clinic, led by geneticist Fergus Couch, identified specific genes associated with triple-negative breast cancer. Triple-negative breast cancer is generally difficult to treat and has a lower five-year survival rate than other types of breast cancer.